Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Phytother Res ; 29(11): 1798-805, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26343251

ABSTRACT

The Eugenia jambolana is used in folklore medicine. Leaves of E. jambolana contain flavonoids as their active constituents which possess in vitro antiinflammatory, antioxidant and the antimicrobial activity. The aim of the present study was to investigate the antiinflammatory and antioxidant effects of a flavonoid glucoside, trimeric myricetin rhamnoside (TMR) isolated from leaves of E. jambolana. TMR was studied for antiinflammatory activity in carrageenan-induced hind paw oedema and antioxidant activity in lung by caecal ligation and puncture (CLP)-induced sepsis in mice. Results of the present study indicated that TMR significantly attenuated the oedema, myeloperoxidase (MPO), cytokines and prostaglandin levels in the paw after 5 h of carrageenan injection as compared to vehicle control. It also reduced the lung MPO, lipid peroxides, and serum nitrite plus nitrate levels and increased lung reduced glutathione levels 20 h of CLP as compared to vehicle control. Thus the results of this study concluded that the TMR appears to have potential benefits in diseases that are mediated by both inflammation and oxidative stress and support the pharmacological basis of use of E. jambolana plant as traditional herbal medicine for the treatment of inflammatory diseases.


Subject(s)
Antioxidants/pharmacology , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Syzygium , Animals , Anti-Inflammatory Agents/pharmacology , Carrageenan/adverse effects , Cecum , Edema/drug therapy , Flavonoids , Glutathione/metabolism , Inflammation/chemically induced , Inflammation/drug therapy , Ligation , Lung/drug effects , Male , Mice , Peroxidase/metabolism , Phytotherapy , Plant Leaves/metabolism , Punctures , Rats , Rats, Wistar , Sepsis/drug therapy
2.
Connect Tissue Res ; 55(5-6): 367-77, 2014.
Article in English | MEDLINE | ID: mdl-25111192

ABSTRACT

The aim of the present study was to evaluate in vivo modulatory effect of S-methylisothiourea (SMT), a preferential inhibitor of inducible nitric oxide synthase (iNOS) on pain and pathology in the surgical model of osteoarthritis (OA) in rats. The OA was produced by the anterior cruciate ligament transection (ACLT) and medial meniscectomy (MMx) of right knee. SMT was administered 1 day prior to the production of OA and continued up to day 42 postoperation. Mechanical hyperalgesia, thermal hyperalgesia, tail flick latency after repeated flexion and extension of OA knee and knee diameter of right knee were determined at weekly intervals. Serum levels of IL-1ß, TNF-α and nitrite concentration were determined at the end of the experiment. Glycosaminoglycan (GAG) content, collagen content and histopathological evaluation of articular cartilage were also determined at the end of the experiment. SMT reduced mechanical hyperalgesia and the serum levels of IL-1ß, TNF-α and nitrite. Further, SMT reduced the loss of GAG from articular cartilage. Microscopically, SMT reduced the severity of the cartilage lesion. The results indicate the effectiveness of SMT in attenuating the pain and pathology of experimental OA phase by reducing the production of nitric oxide and interleukin-1ß and tumor necrosis factor-α, which are known to play a major role in the pathophysiology of OA.


Subject(s)
Arthralgia/drug therapy , Arthralgia/pathology , Isothiuronium/analogs & derivatives , Nitric Oxide Synthase Type II/antagonists & inhibitors , Osteoarthritis/complications , Analysis of Variance , Animals , Anterior Cruciate Ligament/surgery , Arthralgia/etiology , Histological Techniques , Hyperalgesia/drug therapy , Interleukin-1beta/blood , Isothiuronium/pharmacology , Male , Menisci, Tibial/surgery , Nitrites/blood , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/blood
3.
J Pharm Pharmacol ; 66(7): 1021-31, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24697299

ABSTRACT

OBJECTIVES: To study the chondroprotective and anti-inflammatory potential of inducible nitric oxide synthase (iNOS) inhibitor S-methylisothiourea (SMT) in in-vitro model. METHODS: Rabbit cartilage explants were stimulated with recombinant human interleukin 1ß (rhIL-1ß), and the chondroprotective and anti-inflammatory effects of SMT were investigated. Rat synovial explants were stimulated with LPS, and the anti-inflammatory effect of SMT on synovium was studied. To examine the role of SMT in synovial inflammation mediated cartilage damage, LPS stimulated synovial explants were cultured with dead cartilage with or without SMT for 72 h. The culture medium was analysed for sulfated glycosaminoglycans (GAGs) and hydroxyproline as measure of proteoglycans and collagen degradation, respectively. KEY FINDINGS: SMT significantly reduced GAGs, hydroxyproline, matrix metalloproteinase (MMP)-13, tumour necrosis factor alpha (TNF-α), prostaglindin E2 (PGE2 ) and nitrite release in stimulated rabbit cartilage media indicating chondroprotective and anti-inflammatory effects of SMT in osteoarthritis (OA). Stimulated synovial explants caused release of nitrite, PGE2 , IL-1ß and TNF-α in the medium which were significantly reduced by SMT indicating its anti-inflammatory action. SMT significantly reduced GAGs and hydroxyproline in medium and shown protective effect against synovium-mediated cartilage damage. CONCLUSIONS: SMT inhibited cartilage degradation, synovial inflammation and synovium-mediated cartilage damage, suggesting that SMT may be an agent for pharmacological intervention in OA.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cartilage, Articular/drug effects , Chondrocytes/drug effects , Isothiuronium/analogs & derivatives , Nitric Oxide Synthase Type II/antagonists & inhibitors , Osteoarthritis/drug therapy , Synovial Membrane/drug effects , Animals , Anti-Inflammatory Agents/pharmacology , Cartilage, Articular/metabolism , Chondrocytes/metabolism , Cytokines/metabolism , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Glycosaminoglycans/metabolism , Humans , Hydroxyproline/metabolism , In Vitro Techniques , Inflammation/drug therapy , Inflammation/metabolism , Inflammation Mediators/metabolism , Isothiuronium/pharmacology , Isothiuronium/therapeutic use , Lipopolysaccharides , Male , Matrix Metalloproteinase 13/metabolism , Nitrites/metabolism , Osteoarthritis/metabolism , Rabbits , Rats , Rats, Wistar , Synovial Membrane/metabolism
4.
Neurochem Int ; 68: 1-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24513038

ABSTRACT

Atorvastatin is an HMG-CoA reductase inhibitor used in the treatment of hypercholesterolemia and prevention of coronary heart disease. Oxidative stress is considered to be one of the main causes of neuropathic pain after nerve injury. This study aimed to investigate the effect of atorvastatin on oxidative stress and hyperalgesia in chronic constriction injury (CCI) model of neuropathic pain. Pain behaviour in rats was evaluated before and after atorvastatin administration using mechanical and heat hyperalgesia. The markers for oxidative stress in sciatic nerve, spinal cord and pre-frontal cortex (PFC) area of brain were biochemically detected in vehicle and atorvastatin-treated neuropathic CCI rats. Atorvastatin attenuated hyperalgesia. We found a significant increase in malondialdehyde (MDA), nitric oxide (NO), superoxide anion (O2(-)) and protein carbonyl along with a reduction in catalase (CAT), reduced glutathione (GSH), total thiol (SH) and glutathione-S-transferase (GST) and; increase in superoxide dismutase (SOD) levels in the sciatic nerve, spinal cord and PFC of the CCI-induced neuropathic rats. Reduced levels of enzymatic and non enzymatic antioxidants were restored by atorvastatin. The levels of MDA, O2(-), and protein carbonyl in these tissues were significantly reduced in the atorvastatin-treated CCI rats compared to the untreated CCI rats. Our study demonstrated that atorvastatin attenuates neuropathic pain through inhibition of oxidative stress in sciatic nerve, spinal cord and brain suggesting antioxidants as potential drugs in neuropathic pain management. This study provides a new application of atorvastatin in treatment of neuropathic pain.


Subject(s)
Heptanoic Acids/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Neuralgia/drug therapy , Oxidative Stress/drug effects , Pyrroles/pharmacology , Sciatic Nerve/drug effects , Spinal Cord/drug effects , Animals , Antioxidants/therapeutic use , Atorvastatin , Down-Regulation , Hyperalgesia/complications , Hyperalgesia/drug therapy , Male , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...